PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Travere Therapeutics, Inc.
Filed: April 17, 2015
Period of Report: April 17, 2015
Accession Number: 0001193125-15-136141

View Document ↗ View on SEC.gov ↗